Roxadustat Capsules 20mg

Roxadustat Capsules 20mg

$2.00

Roxadustat Capsules (Vibei Ai) provide 20mg of roxadustat per capsule in a pack of 3 capsules. Produced by Jiangxi Shanxiang Pharmaceutical Co., Ltd., approved by China NMPA (H20249730). Intended for laboratory research use only. Wholesale and retail available.?Please consult staff for price, other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare
分类:

描述

Roxadustat is a potent oral hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitor that stimulates erythropoiesis by stabilizing HIF, leading to increased endogenous erythropoietin production. It is widely researched for its potential in treating anemia associated with chronic kidney disease (CKD) and other hypoxia-related conditions.

This product contains 20mg roxadustat per capsule, provided in 3 capsules per box, designed for in vitro and in vivo research applications such as anemia models, oxygen sensing pathways, and metabolic regulation studies.

Manufactured by Jiangxi Shanxiang Pharmaceutical Co., Ltd. under Qingfeng Pharmaceutical Group, this product is approved by China’s NMPA under number H20249730 and product code 86905345000626.

?? Strictly for laboratory research use only. Not for human or veterinary use.


Product Specifications

Parameter Details
Product Name Roxadustat Capsules (Vibei Ai)
Generic Name Roxadustat
CAS Number 808118-40-3
Molecular Formula C21H23N3O5
Molecular Weight 351.43 g/mol
Dosage Form Capsule
Strength 20mg per capsule
Quantity 3 capsules per box
Approval Number H20249730 (China NMPA)
Product Code 86905345000626
Manufacturer Jiangxi Shanxiang Pharmaceutical Co., Ltd.
Barcode 6925825306066
Intended Use Laboratory research only
Storage Conditions Store sealed below 25°C, protected from moisture and light

Mechanism & Research Applications

Roxadustat inhibits HIF prolyl hydroxylase enzymes, preventing HIF degradation under normoxic conditions. Stabilized HIF activates transcription of genes involved in erythropoiesis and iron metabolism, resulting in increased production of endogenous erythropoietin and improved red blood cell formation.

This mechanism makes roxadustat a valuable compound for research on anemia of chronic kidney disease, hypoxia-related disorders, and oxygen sensing pathways.

Research applications include in vitro cell assays, animal models of anemia and hypoxia, gene expression studies related to HIF pathways, and metabolic regulation investigations.


Safety & Handling

  • Use Restriction: For laboratory research only; not for clinical, diagnostic, or veterinary use.

  • Protective Equipment: Use gloves, lab coat, and eye protection when handling.

  • Storage: Keep sealed and stored below 25°C, away from moisture and direct sunlight.

  • Disposal: Dispose of according to institutional and environmental safety protocols.


Research Use Disclaimer

This product is intended exclusively for laboratory research. It is not approved for therapeutic, diagnostic, or veterinary applications. Misuse may pose safety and legal risks. Always follow institutional biosafety and handling protocols.

其他信息

重量 1 公斤
尺寸 26 × 23 × 26 厘米

评价

目前还没有评价

成为第一个“Roxadustat Capsules 20mg” 的评价者

您的邮箱地址不会被公开。 必填项已用 * 标注

Q1: Is Roxadustat Capsules (Vibei Ai) approved for human use?

A1: No, this product is intended strictly for laboratory research purposes and is not approved for clinical or veterinary use.

Q2: Are bulk purchases available?

A2: Yes, wholesale and retail options are supported. Please contact us for further details.

Q3: Can I get a Certificate of Analysis (COA) and Safety Data Sheet (SDS)?

A3: Yes, both COA and SDS are available upon request.

Q4: What research areas is this product best suited for?

A4: Ideal for research on anemia, hypoxia-inducible factor pathways, chronic kidney disease, and oxygen metabolism.

Q5: How is the product packaged?

A5: Each box contains 3 capsules, each with 20mg of roxadustat.


EMI Options

Select at least 2 products
to compare